Sanara MedTech Inc.
NASDAQ:SMTI
33.91 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2001 | 2000 | 1999 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 64.99 | 45.843 | 24.144 | 15.587 | 11.767 | 5.838 | 6.305 | 5.508 | 3.372 | 2.633 | 1.726 | 1.174 | 2.21 | 0.91 | 0.288 | 0.29 | 0.631 | 0.19 | 0.211 | 0.085 | 0.021 | 2.305 | 2.251 |
| Cost of Revenue
| 11.528 | 6.361 | 2.311 | 1.617 | 1.209 | 0.507 | 0.806 | 0.944 | 0.892 | 0.804 | 0.793 | 0.799 | 0.8 | 0.538 | 1.105 | 0.417 | 0.223 | 0.193 | 0.271 | 0.08 | 0.02 | 1.513 | 1.422 |
| Gross Profit
| 53.462 | 39.482 | 21.833 | 13.97 | 10.557 | 5.33 | 5.499 | 4.564 | 2.48 | 1.829 | 0.934 | 0.375 | 1.41 | 0.372 | -0.817 | -0.127 | 0.407 | -0.003 | -0.06 | 0.005 | 0.001 | 0.792 | 0.828 |
| Gross Profit Ratio
| 0.823 | 0.861 | 0.904 | 0.896 | 0.897 | 0.913 | 0.872 | 0.829 | 0.735 | 0.695 | 0.541 | 0.32 | 0.638 | 0.409 | -2.837 | -0.437 | 0.646 | -0.017 | -0.285 | 0.064 | 0.048 | 0.344 | 0.368 |
| Reseach & Development Expenses
| 4.132 | 3.367 | 0.559 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 45.976 | 28.053 | 18.684 | 13.068 | 5.736 | 5.275 | 4.765 | 3.385 | 3.835 | 3.81 | 3.289 | 2.746 | 2.932 | 0.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 56.995 | 45.976 | 28.053 | 18.684 | 13.068 | 5.736 | 5.275 | 4.765 | 3.385 | 3.835 | 3.81 | 3.289 | 2.746 | 2.932 | 0.9 | 1.632 | 0.813 | 0.485 | 0.681 | 0.307 | 1.388 | 1.748 | 1.601 |
| Other Expenses
| 3.675 | 2.371 | 0.597 | 0.291 | 0.12 | -0.022 | 0 | 0 | 0.06 | 0.056 | 0.202 | 2.477 | 0.471 | 0.51 | 0.125 | 0 | 0 | 0 | 0.12 | 5.828 | 0.061 | 0.058 | 0.065 |
| Operating Expenses
| 61.127 | 51.714 | 29.209 | 18.975 | 13.188 | 5.82 | 5.356 | 4.836 | 3.445 | 3.892 | 3.862 | 5.766 | 3.217 | 3.442 | 1.025 | 1.632 | 0.813 | 0.485 | 0.801 | 6.134 | 1.449 | 1.806 | 1.666 |
| Operating Income
| -7.665 | -12.232 | -7.376 | -5.005 | -2.63 | -0.502 | 0.12 | -0.272 | -0.965 | -2.063 | -2.928 | -5.418 | -5.015 | -3.07 | -1.842 | -1.759 | -0.406 | -0.488 | -0.741 | -6.129 | -1.448 | -1.014 | -0.702 |
| Operating Income Ratio
| -0.118 | -0.267 | -0.306 | -0.321 | -0.224 | -0.086 | 0.019 | -0.049 | -0.286 | -0.783 | -1.696 | -4.617 | -2.269 | -3.372 | -6.396 | -6.061 | -0.644 | -2.571 | -3.508 | -72.088 | -69.091 | -0.44 | -0.312 |
| Total Other Income Expenses Net
| 3.225 | -1.705 | -0.618 | 0.559 | -0.206 | -0.025 | 0.315 | 0.031 | -0.199 | 0.078 | 0.506 | 3.666 | -10.95 | -1.421 | -0.46 | -0.014 | -0.137 | -0.136 | 0.034 | -5.828 | -0.3 | -0.088 | -0.005 |
| Income Before Tax
| -4.44 | -13.937 | -7.994 | -4.445 | -2.836 | -0.601 | 0.331 | -0.416 | -1.34 | -2.278 | -4.148 | -1.845 | -12.741 | -5.135 | -2.303 | -1.773 | -0.543 | -0.624 | -0.758 | -6.137 | -1.748 | -1.102 | -0.98 |
| Income Before Tax Ratio
| -0.068 | -0.304 | -0.331 | -0.285 | -0.241 | -0.103 | 0.053 | -0.075 | -0.398 | -0.865 | -2.403 | -1.572 | -5.766 | -5.641 | -7.994 | -6.111 | -0.861 | -3.286 | -3.589 | -72.179 | -83.397 | -0.478 | -0.436 |
| Income Tax Expense
| -0.137 | -5.845 | -0.688 | -0.062 | 0.094 | 0.013 | -0.315 | -0.031 | 0.199 | -0.078 | -0.506 | -3.693 | 10.95 | 1.46 | 0.46 | 0.014 | 0.137 | 0.136 | -0.188 | 5.986 | -0.074 | 0.072 | -0.496 |
| Net Income
| -4.303 | -8.092 | -7.306 | -4.383 | -2.93 | -0.601 | 0.331 | -0.416 | -1.34 | -2.278 | -4.148 | -1.845 | -12.741 | -5.135 | -2.303 | -1.773 | -0.543 | -0.624 | -0.758 | -6.295 | -1.53 | -1.102 | 0.478 |
| Net Income Ratio
| -0.066 | -0.177 | -0.303 | -0.281 | -0.249 | -0.103 | 0.053 | -0.075 | -0.398 | -0.865 | -2.403 | -1.572 | -5.766 | -5.641 | -7.994 | -6.111 | -0.861 | -3.286 | -3.589 | -74.046 | -72.994 | -0.478 | 0.212 |
| EPS
| -0.52 | -1.02 | -1 | -0.76 | -1.37 | -0.28 | 0.17 | -0.38 | -1.26 | -2.16 | -4.84 | -2.68 | -21.69 | -14.34 | -7.92 | -8.08 | -3.36 | -3.86 | -4.84 | -68.92 | -2.15 | -1.59 | -0.7 |
| EPS Diluted
| -0.52 | -1.02 | -1 | -0.76 | -1.37 | -0.28 | 0.092 | -0.38 | -1.25 | -2.16 | -4.84 | -2.68 | -21.69 | -14.34 | -7.92 | -8.08 | -3.36 | -3.86 | -4.84 | -68.92 | -2.15 | -1.59 | -0.7 |
| EBITDA
| -3.99 | -10.241 | -7.396 | -4.698 | -2.5 | -0.418 | 0.223 | -0.211 | -0.905 | -2.006 | -2.877 | -5.191 | -1.058 | -2.402 | -1.704 | -1.745 | -0.386 | -0.466 | -0.879 | -0.277 | -1.387 | -0.956 | -0.768 |
| EBITDA Ratio
| -0.061 | -0.223 | -0.306 | -0.301 | -0.212 | -0.072 | 0.035 | -0.038 | -0.268 | -0.762 | -1.666 | -4.423 | -0.479 | -2.639 | -5.918 | -6.013 | -0.612 | -2.456 | -4.163 | -3.256 | -66.175 | -0.415 | -0.341 |